Feline Acromegaly: Welfare in an Underdiagnosed Condition

Acromegaly caused by a pituitary tumor is increasingly recognized as a common cause of poorly controlled diabetes in cats and carries significant welfare implications.

Key Facts

Acromegaly affects an estimated 25-30% of cats with poorly regulated diabetes mellitus
A growth-hormone secreting pituitary adenoma drives insulin resistance and progressive organomegaly
Affected cats require very high insulin doses and rarely achieve good glycemic control without tumor treatment
MRI and CT scanning can identify pituitary tumors as small as 3-4mm
Radiation therapy targeting the pituitary tumor can dramatically improve insulin sensitivity and quality of life

Welfare Considerations

Undiagnosed acromegaly condemns cats to poorly controlled diabetes with persistent hyperglycemia causing neuropathy, lethargy, and chronic malaise. Owners and veterinarians may blame inadequate insulin dosing rather than recognizing the underlying tumor. Awareness of acromegaly as a cause of refractory diabetes is critical to welfare, as appropriate diagnosis opens treatment pathways that substantially improve daily comfort and longevity. The condition disproportionately affects middle-aged to older male cats.

What You Can Do

Ask your vet about acromegaly testing if your diabetic cat requires very high insulin doses
Support veterinary specialist referral for advanced imaging when diabetes is poorly controlled
Advocate for increased awareness of feline acromegaly in general practice continuing education
Consider clinical trial participation at veterinary schools researching pituitary tumor treatment